Managing Intellectual Property once again hosted the European Patent Reform Forum this year in New York on December 8 and San Jose on December 10.
View the New York brochure
View the San Jose brochure
With final decisions of the European Patent Reform and the Unified Patent Court
imminent, it is essential that the specifics are understood in order to make the necessary adjustments to your strategy. The MIP European Patent Reform USA event examined the new court and financial considerations of the unitary patent in detail and took an in-depth look at the most pressing issues for US companies.
By examining the final steps and most recent updates on the European Patent
Reform, this forum provided an invaluable analysis of the details and specifics of
the UPC, financial considerations of the unified patent and patent enforcement
strategies. With an in-depth analysis of global litigation under the new court this
forum helped delegates to finalise their strategies and understand how to stay one step ahead of competitors.
The programme addressed the major issues at hand and encouraged participation
and debate on all the pertinent topics and technical matters from the varied
perspectives of a wide range of stakeholders. MIP brought the agenda its global
expertise so as to offer multinational corporations cutting-edge guidance on handling
IP portfolios under the new UPC. The MIP European Patent Reform USA 2015
brought together leaders in corporations, industry associations and leading legal
experts to discuss and impart valuable knowledge.
Benefits of attending:
- Understand and determine the specifics of the UPC and Unitary Patent
- Discuss the implications of the court and renewal fees on your budget and strategies to prepare for the costs
- Assess the use of opposition proceedings and cost saving alternative IP strategies
- Join analysis on litigation planning and forum shopping in the Unified Patent Court
- Listen to patent enforcement strategies to determine what is right for your business
- Examine the impact of the UPC on the life sciences, pharma and IT and technology sectors
Who was there:
- IP in-house counsel
- General counsel
- Private practice lawyers
- Heads of IP
- Heads of legal
- Patent counsel